Variant report
Variant | esv3449696 |
---|---|
Chromosome Location | chr9:36352-42150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:123)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr9:38287-38723 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr9:37157-39076 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr9:36125-36663 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr9:36130-36607 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr9:38050-38808 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr9:38292-38653 | K562 | blood: | n/a | n/a |
7 | CEBPD | chr9:36082-36868 | K562 | blood: | n/a | n/a |
8 | CEBPD | chr9:38248-38794 | K562 | blood: | n/a | n/a |
9 | EP300 | chr9:37211-37606 | GM12878 | blood: | n/a | n/a |
10 | EP300 | chr9:38608-38885 | GM12878 | blood: | n/a | n/a |
11 | EP300 | chr9:37872-38229 | GM12878 | blood: | n/a | n/a |
12 | FOSL2 | chr9:38786-39387 | HepG2 | liver: | n/a | n/a |
13 | FOSL2 | chr9:36185-36746 | HepG2 | liver: | n/a | chr9:36583-36592 chr9:36585-36592 chr9:36582-36593 |
14 | FOSL2 | chr9:38174-38766 | HepG2 | liver: | n/a | chr9:38490-38501 |
15 | FOSL2 | chr9:37361-38199 | HepG2 | liver: | n/a | chr9:37730-37741 |
16 | FOSL2 | chr9:39038-39334 | HepG2 | liver: | n/a | n/a |
17 | FOSL2 | chr9:38220-38944 | HepG2 | liver: | n/a | chr9:38490-38501 |
18 | FOSL2 | chr9:39682-39993 | HepG2 | liver: | n/a | n/a |
19 | FOSL2 | chr9:36188-36536 | HepG2 | liver: | n/a | n/a |
20 | GABPA | chr9:37782-38271 | Hela-S3 | cervix: | n/a | n/a |
21 | GABPA | chr9:38627-38911 | Hela-S3 | cervix: | n/a | n/a |
22 | GABPA | chr9:37709-37837 | Hela-S3 | cervix: | n/a | n/a |
23 | GABPA | chr9:38445-38604 | Hela-S3 | cervix: | n/a | n/a |
24 | GABPA | chr9:36192-36569 | Hela-S3 | cervix: | n/a | n/a |
25 | GABPA | chr9:37189-37769 | Hela-S3 | cervix: | n/a | n/a |
26 | GABPA | chr9:36241-36396 | Hela-S3 | cervix: | n/a | n/a |
27 | GABPA | chr9:38307-38923 | Hela-S3 | cervix: | n/a | n/a |
28 | GABPA | chr9:39031-39302 | Hela-S3 | cervix: | n/a | n/a |
29 | GABPA | chr9:37456-37634 | Hela-S3 | cervix: | n/a | n/a |
30 | GATA2 | chr9:33620-37011 | K562 | blood: | n/a | chr9:36660-36670 chr9:36639-36648 chr9:36582-36591 |
31 | GATA2 | chr9:37081-39456 | K562 | blood: | n/a | n/a |
32 | HEY1 | chr9:37037-39347 | K562 | blood: | n/a | n/a |
33 | HEY1 | chr9:35288-39469 | K562 | blood: | n/a | n/a |
34 | HEY1 | chr9:39673-40233 | K562 | blood: | n/a | n/a |
35 | HEY1 | chr9:35610-37008 | K562 | blood: | n/a | n/a |
36 | HEY1 | chr9:36257-36529 | HepG2 | liver: | n/a | n/a |
37 | JUND | chr9:39666-40079 | HepG2 | liver: | n/a | n/a |
38 | JUND | chr9:38392-38592 | HepG2 | liver: | n/a | n/a |
39 | JUND | chr9:37682-37870 | HepG2 | liver: | n/a | chr9:37730-37741 |
40 | JUND | chr9:37955-38155 | HepG2 | liver: | n/a | n/a |
41 | JUND | chr9:36182-36642 | HepG2 | liver: | n/a | chr9:36583-36592 chr9:36585-36592 chr9:36582-36593 |
42 | JUND | chr9:37154-37339 | HepG2 | liver: | n/a | n/a |
43 | JUND | chr9:38317-38986 | HepG2 | liver: | n/a | n/a |
44 | NR2F2 | chr9:38282-38691 | K562 | blood: | n/a | n/a |
45 | NR2F2 | chr9:36011-36908 | K562 | blood: | n/a | n/a |
46 | NR2F2 | chr9:37135-39057 | K562 | blood: | n/a | n/a |
47 | PAX5 | chr9:37551-37859 | GM12878 | blood: | n/a | chr9:37766-37776 |
48 | PAX5 | chr9:39049-39268 | GM12878 | blood: | n/a | n/a |
49 | PAX5 | chr9:36179-36780 | GM12878 | blood: | n/a | n/a |
50 | PAX5 | chr9:39737-39892 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FAM138C | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79012958 | chr9:36508-36509 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs201244578 | chr9:37221-37222 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs202182986 | chr9:37345-37346 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs200492591 | chr9:37371-37372 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs201767999 | chr9:37499-37500 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs199544297 | chr9:37619-37620 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs200271684 | chr9:37822-37823 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs201113295 | chr9:37925-37926 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs199728703 | chr9:38185-38186 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs111825891 | chr9:38302-38303 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs200674775 | chr9:38388-38389 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs571252699 | chr9:38404-38405 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs201653007 | chr9:38524-38525 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs199643581 | chr9:38797-38798 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs367841173 | chr9:38962-38963 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs372029425 | chr9:38967-38968 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs376864329 | chr9:38985-38986 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs806724 | chr9:39002-39003 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs9406929 | chr9:39006-39007 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs62531189 | chr9:39012-39013 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs62531190 | chr9:39029-39030 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs2492179 | chr9:39037-39038 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs142178595 | chr9:39039-39040 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs9408135 | chr9:39043-39044 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs201977229 | chr9:39071-39072 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs573190378 | chr9:39150-39151 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs370266944 | chr9:39161-39162 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs11489804 | chr9:39188-39189 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs369395128 | chr9:39205-39206 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs375971758 | chr9:39212-39213 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs370661236 | chr9:39222-39223 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs574475982 | chr9:39269-39270 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs373058508 | chr9:39270-39271 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs9408136 | chr9:39360-39361 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs201124578 | chr9:39384-39385 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs202212918 | chr9:39386-39387 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs200367069 | chr9:39404-39405 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs76661657 | chr9:39413-39414 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs187822601 | chr9:39423-39424 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs80126795 | chr9:39444-39445 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs574074175 | chr9:39448-39449 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs188840810 | chr9:39457-39458 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs62531193 | chr9:39458-39459 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs544660474 | chr9:39459-39460 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs368048139 | chr9:39486-39487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs80129253 | chr9:39504-39505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76387137 | chr9:39508-39509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533391126 | chr9:39513-39514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs62531194 | chr9:39516-39517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560476398 | chr9:39517-39518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164920 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:39400-40200 | Enhancers | K562 | blood |
2 | chr9:40200-41200 | Weak transcription | K562 | blood |
3 | chr9:40800-41200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr9:41000-42000 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr9:41000-42000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
6 | chr9:41200-41600 | Enhancers | K562 | blood |
7 | chr9:41200-41600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
8 | chr9:41600-42400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr9:41600-43800 | Weak transcription | K562 | blood |